Skip to main content
Fig. 3 | Journal of Ovarian Research

Fig. 3

From: Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo

Fig. 3

OVE cells are most sensitive to metabolic inhibition with simvastatin treatment. OVE cells (n = 3/group) were treated with varying doses (0.001uM-1000uM) of simvastatin, atorvastatin, rosuvastatin or pravastatin for 24 h and then subjected to a resazurin sodium salt cell metabolic assay. Bars represent mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001)

Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us